Onsite Tobacco Cessation Treatment in Patients with Peripheral Artery Disease

This clinical trial studies the feasibility of establishing an on-site visit with a tobacco treatment specialist for patients with peripheral artery disease (PAD) treated at the University of Oklahoma (OU) Cardiovascular Institute Limb Preservation Clinic (LPC). Tobacco cessation treatment is needed for individuals with PAD to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. Integrating tobacco cessation services into a dedicated onsite PAD clinic may be able to improve tobacco cessation rates and improve PAD-related health outcomes.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05469698.

Trial PhaseNo phase specified

Trial Typeprevention

Lead OrganizationUniversity of Oklahoma Health Sciences Center

Principal InvestigatorDarla Kendzor

• Primary IDOU202010DK-PAD
• Secondary IDsNCI-2022-10244
• ClinicalTrials.gov IDNCT05469698